Related Experiment Videos
Prophylaxis in ovarian cancer
1Cornell University Medical College, New York, New York.
Cancer
|February 15, 1993
Summary
Oral contraceptive pills significantly reduce ovarian cancer incidence by 40% with long-term use, potentially preventing 1500 cases annually. Early detection of ovarian tumors in postmenopausal women is crucial for timely intervention.
Area of Science:
- Gynecologic Oncology
- Preventive Medicine
Background:
- Ovarian cancer is the leading cause of gynecologic cancer death.
- Prophylaxis options for ovarian cancer are limited, with oophorectomy being the primary method.
- High-risk individuals include those with a strong family history of premenopausal ovarian cancer.
Purpose of the Study:
- To explore prophylaxis and prevention strategies for ovarian cancer.
- To highlight the role of oral contraceptives in reducing ovarian cancer incidence.
- To clarify the significance of postmenopausal palpable ovary syndrome.
Main Methods:
- Literature review on ovarian cancer prophylaxis.
- Analysis of data on oral contraceptive pill usage and ovarian cancer risk.
- Definition and differentiation of postmenopausal palpable ovary syndrome from sonographic findings.
Main Results:
- Oral contraceptive pill use for 4-5 years decreases ovarian cancer incidence by approximately 40%.
- Oral contraceptives are estimated to prevent about 1500 ovarian cancers annually.
- Postmenopausal palpable ovary syndrome indicates a potential ovarian tumor, distinct from small cysts.
Conclusions:
- Long-term oral contraceptive use is a viable strategy for ovarian cancer prevention.
- Awareness of family history and postmenopausal changes aids in early detection and risk assessment.
- Further research into ovarian cancer prophylaxis is essential given its high mortality rate.